Malignancy in the HIV-infected patients undergoing liver and kidney transplantation

Current Opinion in Oncology

Volumn 24, Issue 5, 2012, Pages 517-521

  Nissen, Nicholas N ^a   Barin, Burc ^b   Stock, Peter G ^c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b EMMES CORPORATION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

hepatocellular carcinoma; human immunodeficiency virus; malignancy; transplantation

Indexed keywords

RAPAMYCIN;

ACUTE GRAFT REJECTION; CANCER RISK; DISEASE ASSOCIATION; GRAFT SURVIVAL; HEPATITIS C; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; NEOPLASM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SURVIVAL; TREATMENT OUTCOME;

HIV INFECTIONS; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; NEOPLASMS;

EID: 84865513588     PISSN: 10408746     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/CCO.0b013e328355e0d7     Document Type: Review

References (16)

1. Solid organ transplantation in HIV: multi-site study. In: ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine (US). 2000 [cited 01 April 2012]. Available from http://clinicaltrials.gov/ct2/show/ NCT00074386. NLM Identifier: NCT00074386.
2. Stock PG, Barin B, Murphy B, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 2010; 363:2004-2014;
3. Erratum in N Engl J Med 2011; 364:1082. This study describes the outcomes of 150 HIV-positive patients undergoing kidney transplant in a U.S. multicenter trial. Patient and graft survival results are reported and are excellent, and although acute cellular rejection was common, HIV progression was rare.
4. Coffin CS, Stock PG, Dove LM, et al. Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients. Am J Transplant 2010; 10:1268-1275.
5. Terrault NA, Roland ME, Schiano T, et al. Outcomes of liver transplantation in HCV-HIV coinfected recipients. Liver Transpl 2012; 18:716-726.
6. Cooper C, Kanters S, Klein M, et al. Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohort. AIDS 2011; 25:777-786.
7. Samri A, Roque-Afonso AM, Beran O, et al. Preservation of immune function and antihepatitis Cvirus (HCV) immune responses after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 'THEVIC' trial). J Hepatol 2009; 51:1000-1009.
8. Bourcier V, Winnock M, Ait Ahmed M, et al. Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir). Clin Res Hepatol Gastroenterol 2012; 36:214-221.
9. Berretta M, Garlassi E, Cacopardo B, et al. Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. Oncologist 2011; 16:1258-1269.
10. 3 Aquitaine Cohort, France, 1998-2008. J Hepatol 2011; 55:1058-1062.
11. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-699. (Pubitemid 26079803)
12. Vibert E, Duclos-Vallée JC, Ghigna MR, et al. Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection. Hepatology 2011; 53:475-482; doi: 10.1002/hep. 24062.
13. Di Benedetto F, Tarantino G, De Ruvo N, et al. University of Modena experience in HIV-positive patients undergoing liver transplantation. Transplant Proc 2011; 43:1114-1118.
14. Di Benedetto F, Di Sandro S, De Ruvo N, et al. Kaposi's sarcoma after liver transplantation. J Cancer Res Clin Oncol 2008; 134:653-658. (Pubitemid 351506416)
15. Stallone G, Schena A, Infante B, et al. Sirolimus for Kaposi's sarcoma in renal transplant recipients. N Engl J Med 2005; 352:1317-1323. (Pubitemid 40411498)
16. Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011; 306:1891-1901.